News Daily News Weight Loss Drugs Show Promise for Secondary Prevention in PAD L.A. McKeown February 04, 2026
News Daily News Cardiologists Lack Resources to Help Hospitalized Patients Quit Smoking L.A. McKeown January 08, 2026
News Daily News Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Caitlin E. Cox October 22, 2025
News Daily News Getting Ready for a Heart Failure Polypill, Well Before the Data Are In Todd Neale October 16, 2025
News Daily News Is It Time for an ‘Interventional Heart Failure’ Subspecialty? Yael L. Maxwell February 19, 2025
News Daily News Early Actions by Trump Administration Sow Uncertainty for CV Research Todd Neale January 30, 2025
News Daily News Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple L.A. McKeown December 09, 2024
News Daily News Little Pre- and Postmarket Testing for Most Recalled CV Devices Michael O'Riordan September 16, 2024
News Daily News Payment Parity for Telehealth Linked to Better BP Treatment Michael O'Riordan August 07, 2024
News Daily News FDA Medical Devices Chief Jeff Shuren Announces Retirement L.A. McKeown July 24, 2024
News Daily News AHA Marks 100 Years: ‘We Truly Stand on the Shoulders of Giants’ L.A. McKeown January 08, 2024
News Daily News Meth-Related HF: Challenges at the Intersection of CVD and Addiction Caitlin E. Cox December 06, 2022
News Daily News More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials Michael O'Riordan October 28, 2022
News Daily News New Biomarker-Based Risk Score Performs Well in ACS Michael O'Riordan October 25, 2022
News Daily News AI Tool Can Quantify CAC—and Associated CV Risk—From PET Yael L. Maxwell September 14, 2022
News Daily News Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive Michael O'Riordan September 09, 2022
News Daily News After COVID-19, Unvaccinated at Risk for Long-term CVD Complications Michael O'Riordan August 16, 2022